$BMO

Bank Of Montreal (BMO) Stock Forecasts

Argus reported on Aug 12, 2026 that it raised its price target for Bank of Montreal (BMO) to $199.00. The article cites an earnings estimate of $183.57 and describes BMO as a North American diversified financial-services provider with over CAD 1.4 trillion in assets.

Original reporting
Published Aug 13, 2026, 12:13 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 1:19 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$BMO
Bullish
medium confidence
Mentioned
$BMO
Relevance
4/10
alphai data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$BMOBullishLow
01

Why it matters

The only concrete new fact is the raised price target to $199 for Bank of Montreal, with an earnings estimate shown as $183.57.

02

Market read

Traders may use the target raise as a short-term sentiment catalyst, but there is no new fundamental disclosure in the provided body.

03

What to watch

The body does not state the upgrade rationale, valuation assumptions, or changes to earnings estimates beyond the single figure, limiting conviction.

Relevance 4/10Novelty 4/10Timing: analyst note dated Aug 12, 2026, likely relevant for near-term trading

Background

The text is a Yahoo Finance snippet referencing an Argus report dated Aug 12, 2026.

Company-level read

Ticker impact

$BMOBullishMedium confidence
Context

Argus upgraded Bank of Montreal, raising its price target to $199 and citing an earnings estimate of $183.57.

Expected impact

Mild positive bias for the next session or two, with follow-through dependent on whether the market already priced in the upgrade.

Evidence & confidence

A target increase is actionable for traders, but the body provides no new company-specific operational or financial datapoint, only the analyst action and estimates.

Market effects

Limited read-through to Canadian financials because the article contains only a single-name analyst target change.

Potential small sentiment spillover to Canadian bank peers, but no peer-specific catalysts are provided.

Minimal global impact; this is a localized sell-side update.

Counterpoint

If the market already expected an upgrade, the incremental impact may fade quickly and the stock could mean-revert.

Key entities

  • Bank of Montreal

    Subject of the article, with an Argus price-target increase to $199.

  • Argus

    Broker/research firm issuing the upgrade and target change.

Related articles

$RBCMed

Canadian trade officials in Washington, Moneris sale to U.S. private equity and Air Canada sells 25% of Aeroplan stake: Must-read business and investing stories for the week of Aug. 15

The weekly digest covers Canada-US tariff talks ahead of Aug. 19, with Canada warning it would halt talks and retaliate if 50% tariffs take effect. It also reports RBC and BMO plan to sell Moneris to Francisco Partners for about $2B, and Air Canada to sell a 25% Aeroplan stake for $2.5B, valuing Aeroplan above $10B.

$GOLDMed

Stock news for investors: Air Canada, Barrick, Canadian Tire, and more

Cargojet reported quarterly revenue of $275.8M and declared a 38.5c per share cash dividend. RBC and BMO agreed to sell Moneris to Francisco Partners for about $2B, expected by end of FY2027 Q1. Barrick reported Q2 profit of $1.22B, revenue $5.29B, and amended Nevada Gold Mines with Newmont. Air Canada will sell 25% of Aeroplan for $2.5B.

$RYMedAI 8/10

Moneris sale to U.S. owner adds risk to Canada’s data sovereignty, payments industry leaders warn

RBC and BMO said they agreed to jointly sell Moneris Solutions Corp. to California-based Francisco Partners for about $2 billion in cash, with each lender taking a 50% share. The deal raises Canadian data sovereignty concerns. Moneris processes over $5 billion in transactions annually across 325,000 commerce points; regulatory approvals are needed, with expected close by end of fiscal Q1 2027.

$BMOMed

Wednesday’s analyst upgrades and downgrades

TD Cowen analyst Mario Mendonca (TD Cowen) warns Canadian bank multiples could compress as operating leverage and revenue growth moderate, citing CMRR growth slowing and flat NIMs in 2028. He raised targets for BMO, CIBC, and RBC, and adjusted BNS and NB. Raymond James analyst Stephen Boland also updated Big 6 targets. Desjardins analyst Benoit Poirier said Cargojet shares rose after results.

$NDAQMed

Tech M&A deals: Sandbank Acosta, Francisco Partners, Moneris, Nasdaq, LeveL Markets

The article lists recent M&A announcements. Duos Technologies Group sold its rail-technology unit Duos Technologies Inc. to Sandbank Acosta, closing Aug. 5, 2026, terms undisclosed. Francisco Partners agreed to buy Moneris for about C$2 billion cash. Nasdaq agreed to acquire all equity interests in LeveL Markets. Key figures include Moneris’ 325,000 commerce points and about one-third of Canadian transactions.

$BMOMedAI 8/10

RBC and BMO to sell off Canadian payment giant Moneris in $2-billion deal

RBC and BMO agreed to sell their co-owned payment processor Moneris to US private equity firm Francisco Partners for C$2 billion, with each bank receiving 50% of proceeds, according to the banks. The deal is expected to close in early 2027 subject to approvals. Francisco Partners plans to invest in Moneris and appoint Jeff Sloan as chairman.